Tags

Type your tag names separated by a space and hit enter

The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.
Expert Rev Anti Infect Ther. 2011 Dec; 9(12):1133-48.ER

Abstract

Hepatitis E virus (HEV) is an important cause of acute hepatitis in humans worldwide, both as epidemic and sporadic disease. Since the virus was identified in 1983, epidemics have occurred regularly in many countries across South and Southeast Asia when seasonal floods have contaminated drinking water supplies and in Africa during humanitarian crises among refugee populations without access to clean water. In addition, sporadic cases and small clusters of HEV infections have been recognized throughout the world in developed countries over the past couple of decades. This review will focus on emerging evidence of HEV infection as an under-recognized pathogen in Europe, the USA and other industrialized countries. We will discuss some of the issues associated with the recognition, diagnosis and treatment of these sporadic cases. We will also summarize the recent literature on autochthonous HEV infection among populations in developed countries in industrialized Europe, the USA, Japan and other industrialized Asian countries. We will review recent reports of acute and chronic HEV infections among transplant recipients and other immunocompromised individuals including HIV/AIDS patients.

Authors+Show Affiliations

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. kenelson@jhsph.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22114964

Citation

Nelson, Kenrad E., et al. "The Epidemiology of Hepatitis E Virus Infections in Developed Countries and Among Immunocompromised Patients." Expert Review of Anti-infective Therapy, vol. 9, no. 12, 2011, pp. 1133-48.
Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect Ther. 2011;9(12):1133-48.
Nelson, K. E., Kmush, B., & Labrique, A. B. (2011). The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Review of Anti-infective Therapy, 9(12), 1133-48. https://doi.org/10.1586/eri.11.138
Nelson KE, Kmush B, Labrique AB. The Epidemiology of Hepatitis E Virus Infections in Developed Countries and Among Immunocompromised Patients. Expert Rev Anti Infect Ther. 2011;9(12):1133-48. PubMed PMID: 22114964.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. AU - Nelson,Kenrad E, AU - Kmush,Brittany, AU - Labrique,Alain B, PY - 2011/11/26/entrez PY - 2011/11/26/pubmed PY - 2012/4/19/medline SP - 1133 EP - 48 JF - Expert review of anti-infective therapy JO - Expert Rev Anti Infect Ther VL - 9 IS - 12 N2 - Hepatitis E virus (HEV) is an important cause of acute hepatitis in humans worldwide, both as epidemic and sporadic disease. Since the virus was identified in 1983, epidemics have occurred regularly in many countries across South and Southeast Asia when seasonal floods have contaminated drinking water supplies and in Africa during humanitarian crises among refugee populations without access to clean water. In addition, sporadic cases and small clusters of HEV infections have been recognized throughout the world in developed countries over the past couple of decades. This review will focus on emerging evidence of HEV infection as an under-recognized pathogen in Europe, the USA and other industrialized countries. We will discuss some of the issues associated with the recognition, diagnosis and treatment of these sporadic cases. We will also summarize the recent literature on autochthonous HEV infection among populations in developed countries in industrialized Europe, the USA, Japan and other industrialized Asian countries. We will review recent reports of acute and chronic HEV infections among transplant recipients and other immunocompromised individuals including HIV/AIDS patients. SN - 1744-8336 UR - https://www.unboundmedicine.com/medline/citation/22114964/The_epidemiology_of_hepatitis_E_virus_infections_in_developed_countries_and_among_immunocompromised_patients_ L2 - http://www.tandfonline.com/doi/full/10.1586/eri.11.138 DB - PRIME DP - Unbound Medicine ER -